The study aimed to assess the impact of adding a lidocaine infusion for postoperative pain control in ERAS patients undergoing laparoscopic colectomy. The results of the retrospective review showed that patients who received the lidocaine infusion had a significant reduction in postoperative opioid use within the first 48 hours compared to those without it, with a 52% lower median morphine milligram equivalents (MME). This finding highlights the potential of lidocaine infusion as a means to decrease opioid consumption in ERAS patients undergoing laparoscopic colectomy.
Journal Article by Thomas GJ, Bauman JC (…) Ziegler MA et 2 al. in Am Surg
